Jeffrey McCullough - Transfusion Medicine

31 31. Snyder EL, Elfath MD, Taylor H. Collection of two units of leukoreduced RBCs from a single donation with a portable multiple‐component collection system. Transfusion 2003; 43:1695–1705.

32 32. Ikeda K, Ohto H, Nemoto K, et al. Collection of MNCs and progenitor cells by two separators for PBPC transplantation: a randomized crossover trial. Transfusion 2003; 43:814–819.

33 33. Aronson CA, Kakaiya RM, Keene J, et al. Consistency of quality control values for automated double red blood cell collections. Transfusion 2006; 47: 42A.

34 34. Picker SM, Rradojska SM, Gathof BS. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage. Transfusion 2007; 47:687–696.

35 35. Simon TL, Sierra ER, Ferdinando B, Moore R. Collection of platelets with a new cell separator and their storage in a citrate‐plasticized container. Transfusion 1991; 31:335–339.

36 36. Elfath MD, Whitley P, Jacobson MS. Evaluation of an automated system for the collection of packed RBCs, platelets, and plasma. Transfusion 2000; 40:1214–1222.

37 37. Burnouf T, Kappelsberger C, Frank K, Burkhardt T. Protein composition and activation markers in plasma collected by three apheresis procedures. Transfusion 2003; 43:1223–1230.

38 38. Snyder EL, Elfath MD, Taylor H, et al. Collection of two units of leukoreduced RBCs from a single donation with a portable multiple‐component collection system. Transfusion 2003; 43:1695–1705.

39 39. Rugg N, Pitman C, Menitove JE, et al. A feasibility evaluation of an automated blood component collection system platelets and red cells. Transfusion 1999; 39:460–464.

40 40. Dumont LJ, Beddard R, Whitley P, et al. Autologous transfusion recovery of WBC‐reduced high‐concentration platelet concentrates. Transfusion 2002; 42(10):1333–1339.

41 41. Burgstaler EA. Blood component collection by apheresis. J Clin Apher 2006; 21:142–151.

42 42. Valbonesi M, Frisoni R, Florio G, et al. Single‐donor platelet concentrates produced along with packed red blood cells with the Haemonetics MCS 3p: preliminary results. J Clin Apher 1994; 9:195–199.

43 43. Moog R, Zeiler T, Geuft HG, et al. Collection of WBC‐reduced single‐donor PLT concentrates with a new blood cell separator: results for a multicenter study. Transfusion 2003; 43:1107–1114.

44 44. Berger K, Schopohl D, Wittmann G, et al. Blood product supply in Germany: the impact of apheresis and pooled platelet concentrates. Transfus Med Hemother 2016; 43:389–394.

45 45. Surgenor DM, Wallace EL, Hao HS, Chapman RH. Collection and transfusion of blood in the United States, 1982–88. N Engl J Med 1990; 322:1646–1652.

46 46. The 2013 National Blood Collection and Utilization Survey Report, Department of Health and Human Services. Conducted under contract (HHSP23320110008TC) with the American Association of Blood Banks, and using OMB Number 0990–0313.

47 47. Gorlin JB, ed. Standards for Blood Banks and Transfusion Services, 26th edn. Bethesda, MD: American Association of Blood Banks, 2009.

48 48. Slichter SJ. Efficacy of platelets collected by semi‐continuous flow centrifugation (Haemonetics Model 30). Br J Haematol 1978; 38:131–140.

49 49. Katz A, Houx J, Ewald L. Storage of platelets prepared by discontinuous flow centrifugation. Transfusion 1978; 18:220–223.

50 50. Patel IP, Ambinder E, Holland JF, Aledort LM. In vitro and in vivo comparison of single‐donor platelets and multiple‐donor pooled platelets transfusions in leukemic patients. Transfusion 1978; 18:116–119.

51 51. Turner VS, Hawker RJ, Mitchell SG, Seymour Mead AM. Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for five days. J Clin Apher 1994; 9:189–194.

52 52. Maguire LC, Henriksen RA, Strauss RG. Function and morphology of platelets produced for transfusion by intermittent‐flow centrifugation plateletpheresis or combined platelet‐leukapheresis. Transfusion 1981; 21:118–123.

53 53. Daly PA, Schiffer CA, Aisner J, Wiernik PH. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis. Transfusion 1979; 19:778–781.

54 54. Rock GA, Blanchette VS, Wong SC. Storage of platelets collected by apheresis. Transfusion 1983; 23:99–105.

55 55. Meyer D, Bolgiano DC, Sayers M, et al. Red cell collection by apheresis technology. Transfusion 1993; 33:819–824.

56 56. Shi PA, Ness PM. Two‐unit red cell apheresis and its potential advantages over traditional whole‐blood donation. Transfusion 1999; 39:219–225.

57 57. Gilcher RO. It’s time to end RBC shortages. Transfusion 2003; 43:1658–1660.

58 58. Smith JW, Gilcher RO. Red blood cells, plasma, and other new apheresis‐derived blood products: improving product quality and donor utilization. Transfus Med Rev 1999; 13:118–123.

59 59. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis‐collected RBC stored for 42 days. Vox Sang 1998; 75:212–217.

60 60. Bandarenko N, Rose M, Kowalsky J, et al. In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in‐line WBC‐reduction filter. Transfusion 2001; 41:1373–1377.

61 61. Hogler W, Mayer W, Messmer C, et al. Prolonged iron depletion after allogeneic 2‐unit RBC apheresis. Transfusion 2001; 41:602–605.

62 62. Benjamin RJ, Ky BA, Kennedy JM, et al. The relative safety of automated two‐unit red blood cell procedures and manual whole‐blood collection in young donors. Transfusion 2009; 49:1874–1883.

63 63. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974; 44:571–581.

64 64. Mishler JM, Higby DJ, Rhomberg W. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator. Transfusion 1974; 14:352–356.

65 65. Mishler JM, Hester JP, Heustis DW, et al. Dosage and scheduling regimens for erythrocyte‐sedimenting macromolecules. J Clin Apher 1983; 1:130–143.

66 66. Lee JH, Cullis H, Leitman SF, Klein HG. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis. J Clin Apher 1995; 10:198–202.

67 67. Strauss RG. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low‐molecular‐weight hydroxyethyl starch. Vox Sang 1979; 37:268–271.

68 68. Ghodsi Z, Strauss RG. Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001; 41:1464–1468.

69 69. Burch JW, Mair DC, Meny GM, et al. The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion 2005; 45:1701–1708.

70 70. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81:1883–1888.

71 71. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony‐stimulating factor. Blood 1993; 81:2866–2871.

72 72. Liles WC, Huang JE, Llewellyn C, et al. A comparative trial of granulocyte‐colony‐stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997; 37:182–187.

73 73. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36:601–610.